`
`Filed: June 28, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`MYLAN PHARMACEUTICALS, INC.
`Petitioner
`v.
`
` SENJU PHARMACEUTICAL CO., LTD.
`Patent Owner
`_________________
`Case IPR2016-01163
`U.S. Patent 8,877,168
`_________________
`
`PATENT OWNER’S MANDATORY NOTICES
` PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-01163
`U.S. Patent 8,877,168
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Senju Pharmaceutical Co.,
`
`Ltd. hereby submits the following mandatory notices in connection with this
`
`proceeding.
`
`I.
`
`SENJU’S POWER OF ATTORNEY
`
`A Power of Attorney appointing lead and back-up counsel is being filed
`
`concurrently with these Notices.
`
`II.
`
`SENJU’S MANDATORY NOTICES
`
`(a) 37 C.F.R. § 42.8(b)(1): Real Party-in-Interest
`
`The real party-in-interest for the Patent Owner is Senju Pharmaceutical Co.,
`
`Ltd. Other real parties-in-interest include Bausch & Lomb Incorporated and
`
`Bausch & Lomb Pharma Holdings Corp.
`
`(b) Related Matters
`
`1. Judicial
`
`The patent challenged here, U.S. Patent 8,877,168 (“the ’168 patent”), has
`
`been asserted in Bausch & Lomb Incorporated, Bausch & Lomb Pharma Holdings
`
`Corp. and Senju Pharm. Co., Ltd. v. Micro Labs USA, Inc. and Micro Labs
`
`Limited, Civil Action No. 1:15-cv-03113-NLH-JS, in the United States District
`
`Court for the District of New Jersey, filed on May 1, 2015. There is a related
`
`patent, U.S. Patent No. 8,784,789 (“the ’789 patent”), that has been asserted in
`
`
`
`2
`
`
`
`Case IPR2016-01163
`
`U.S. Patent 8,877,168
`
`Bausch & Lomb Incorporated Bausch & Lomb Pharma Holdings Corp. and Senju
`
`Pharm. Co., Ltd. v. Micro Labs USA, Inc. and Micro Labs Limited, Civil Action
`
`No. 1:14-cv—07406-NLH—JS, in the United States District Court for the District of
`
`New Jersey, filed on November 26, 2014.
`
`2. Administrative
`
`A related inter partes review petition has also been filed in relation to the
`
`’789 patent, Mylan Pharmaceuticals, Inc. v Senju Pharmaceuticals Co. Ltd.,
`
`IPR2016-00626, filed on February 25, 2016. Patent Owner additionally notes the
`
`existence of U_S_ Patent No. 8,883,825 (“the ’825 patent”), which issued on
`
`November 11, 2014, based on U.S. Patent Application No. 13/599,212, which is a
`
`division of the ’789 patent. Patent Owner also notes the existence of pending U.S.
`
`Application No. 14/511,393, which is a continuation of the ’825 patent.
`
`(b) 37 C.F.R. § 42.8(b)(3) and (4): Lead and Back—Up Counsel, and
`Service Information
`
`Senju designates the following counsel to transact all business in the United
`
`States Patent & Trademark Office associated with the above-captioned proceeding-
`
`Lead Counsel
`
`Back—Up Counsel
`
`Phone: 202 408-4175
`
`Bryan C. Diner
`(Reg. No. 32,409)
`Finnegan, Henderson, Farabow,
`Garrett & Durmer, LLP
`
`Justin J. Hasford
`(Reg. No. 62,180)
`Finnegan, Henderson, Farabow,
`Garrett & Durmer, LLP
`
`901 New York Avenue, NW
`
`901 New York Avenue, NW
`
`Washington, DC 20001-4413
`Phone: 202 408-4116
`
`Washington, DC 20001-4413
`
`
`
`Fax: (202) 408-4400
`Email: Bryan.Diner@finnegan.com
`
`
`
`
`
`
`Case IPR2016-01163
`U.S. Patent 8,877,168
`Fax: (202) 408-4400
`Email: Justin.Hasford@finnegan.com
`
`Joshua L. Goldberg
`(Reg. No. 59,369)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-6092
`Fax: (202) 408-4400
`Email: Joshua.Goldberg@finnegan.com
`
`Elizabeth D. Ferrill
`(Reg. No. 58,415)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4445
`Fax: (202) 408-4400
`Email: Elizabeth.Ferrill@finnegan.com
`
`Please address all correspondence regarding this proceeding to lead and back-up
`
`counsel. Senju consents to electronic service by email.
`
`Respectfully submitted,
`
`
`
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`
`
`
`4
`
`
`
`Dated: June 28, 2016
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2016-01163
`U.S. Patent 8,877,168
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notices was served on June 28, 2016, via email directed to
`
`counsel of record for the Petitioner at the following:
`
`
`
`Date: June 28, 2016
`
`
`
`Jitendra Malik, Ph.D.
`jitty.malik@alston.com
`
`Hidetada James Abe
`james.abe@alston.com
`
`Lance Soderstrom
`lance.soderstrom@alston.com
`
`Joseph M. Janusz
`Joe.janusz@alston.com
`
`
`/Bradley J. Moore/
`Bradley J. Moore
`Litigation Legal Assistant
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`5